Quality

Making structural improvements in health care

Systemic factors lead to specific practices


 

Every day, hospitalists devote time and energy to the best practices that can limit the spread of infection and the development of antibiotic resistance. Infection Prevention (IP) and Antimicrobial Stewardship (ASP) are two hospital programs that address that same goal.

But there may be a more effective approach possible, according to Jerome A. Leis, MD, MSc, FRCPC, of the Centre for Quality Improvement and Patient Safety at the University of Toronto.

“Despite the high-quality evidence supporting these IP/ASP interventions, our approach to adding these to our current practice sometimes feels like adding scaffolding to a rickety building,” he said. “It supports the underlying structure, but remove the scaffolding without fixing the building, and it may just come tumbling down.” Sometimes the work seems like an uphill battle, he added, as the same problems continue to recur.

That’s because there’s a systemic element to the problems. “Hospitalists know first hand about how the system that we work in makes it difficult to ensure that all the best IP/ASP practices are adhered to all the time,” Dr. Leis said. “Simply reminding staff to remove a urinary catheter in a timely fashion or clean their hands every single time they touch a patient or the environment can only get us so far.” That’s where improvement science comes in.

Pages

Recommended Reading

Negative nasal swabs reliably predicted no MRSA infection
The Hospitalist
Thirty-one percent of multidrug-resistant infections were community acquired
The Hospitalist
Pediatric hospitalists take on the challenge of antibiotic stewardship
The Hospitalist
SHORT TAKES
The Hospitalist
Predicting MDR Gram-negative infection mortality risk
The Hospitalist
Is it time for health policy M&Ms?
The Hospitalist
Drug combo indicated for bacterial pneumonia
The Hospitalist
Paring the risk of antibiotic resistance
The Hospitalist
Reported penicillin allergies hike inpatient costs
The Hospitalist
FDA warns against clarithromycin use in patients with heart disease
The Hospitalist
   Comments ()